Related by context. All words. (Click for frequent words.) 69 MHLW 67 Pirespa 66 Visian Toric ICL 65 Nippon Shinyaku 65 SYCREST 64 Kissei Pharmaceutical 63 cinacalcet HCl 63 methylnaltrexone bromide 63 Nabi HB Intravenous 63 Orphan Drug designations 63 Inavir 62 Levoleucovorin 62 Receives Tentative Approval 62 Taiho Pharmaceutical 62 Announces Tentative Approval 62 Linjeta TM 62 Amlodipine Besylate Tablets 62 Teysuno 62 Plenaxis R 62 successfully commercialize Iluvien 62 TAKEDA 62 5 lipoxygenase inhibitor 61 Amlodipine Besylate 61 Shonin approval 61 PREOS R 61 Preotact 61 Nippon Kayaku 61 miconazole Lauriad ® 61 Seiyaku 61 rheumatoid arthritis Orencia 61 Emezine 61 MOVIPREP R 61 Preotact R 61 ThermoDox R 61 Seikagaku Corporation 61 Thalidomide Pharmion 61 Febuxostat 61 CIP TRAMADOL ER 61 Gonal f 61 Somatuline R Autogel R 61 Dexilant 60 Acurox r Tablets 60 Amitiza lubiprostone 60 Decentralized Procedure 60 Zensana 60 cefuroxime axetil 60 Welfare MHLW 60 Cellegesic 60 Solasia 60 Alvesco R 60 CHMP recommendation 60 Japanese Encephalitis Vaccine 60 balsalazide tablet 60 Raptiva ® 60 Risperidone Oral Solution 60 TEMODAL 60 Oracea ® 60 Granted Orphan Drug 60 XIAFLEX ® 60 sNDAs 60 alogliptin 60 Marketing Authorisation Application MAA 60 liver resection surgeries 60 Sycrest 60 Teijin Pharma Limited 60 Biologic License Application BLA 59 subsidiaries visit http:/www.apricusbio.com 59 AMITIZA R 59 subcutaneous RELISTOR 59 Marketing Authorisation 59 Collategene 59 Topiramate tablets 59 Zidovudine Tablets 59 Trobalt 59 ACUROX ® 59 BRILINTA 59 Loramyc 59 Teijin Pharma 59 Glufast 59 GTC recombinant human 59 udenafil 59 Somatuline Autogel 59 OTC ZEGERID 59 Submits Response 59 Teikoku Seiyaku 59 Bayer Yakuhin Ltd. 59 Dyloject TM 59 Topiramate Tablets 59 CONBRIZA 59 Nivestim 59 INTUNIV TM 59 Santen Pharmaceutical 59 Loramyc TM 59 Sucampo Pharma Ltd. 59 DC Bead 59 Receives Approvable Letter 59 Evoltra ® 59 Fast Track Status 59 Sumatriptan Succinate 59 Application MAA 59 TKPHF 59 Tostrex 58 oxymorphone ER 58 Mycamine 58 Receives Orphan Drug Designation 58 Clevudine 58 Urocidin TM 58 Lubiprostone 58 Drug Eluting Stent System 58 AnGes 58 Alexion Soliris 58 commercialize Hematide 58 apaziquone 58 Recombinant Human 58 Handok Pharmaceuticals 58 Rectogesic 58 Ciclesonide 58 Adenuric R 58 Soliris TM eculizumab 58 Marketing Authorization Applications 58 adenosine injection 58 Ganciclovir 58 histamine dihydrochloride 58 commercialized DURECT 58 Q#IR 58 novel oral anticoagulant 58 Daewoong 58 PrevOnco ™ 58 Zebinix R 58 Ondansetron Injection 58 Allovectin 7 58 refractory chronic lymphocytic 58 Metformin HCl 58 Retacrit 58 BioGlue R 58 Marketing Authorisation Application 58 Receives Marketing Authorization 58 Taro Receives 58 Increlex TM 58 COLAZAL R 58 Fast Track designations 58 Cefprozil 58 Submits Biologics License Application 58 donepezil hydrochloride 58 Zegerid OTC 58 PrevOnco 58 Rapinyl 58 Rotarix R 58 Devices Agency PMDA 58 Hexvix ® 58 VISICOL R 58 Submits NDA 57 miconazole MBT 57 Argatroban 57 Files Investigational 57 FDA Accepts 57 AstraZeneca Symbicort 57 Orphan Drug designation 57 BioGlue ® 57 Glatiramer Acetate 57 Irinotecan Hydrochloride Injection 57 Synvisc ONE 57 Flutiform TM 57 Zensana TM 57 intravenous iv peramivir 57 AMITIZA ® 57 Orapred ODT 57 Taisho Pharmaceuticals 57 Doxycycline Tablets 57 novel emulsion formulation 57 Civacir 57 Asubio 57 Zavesca r 57 GRALISE 57 Serdolect ® 57 Bayer Yakuhin 57 Prestara 57 Mg Uk 57 PREOS 57 Mylan Receives Approval 57 Monovisc 57 Synerx 57 RAPIACTA ® 57 Amitiza ® 57 Pruvel 57 Raptiva R 57 Loramyc R 57 octreotide acetate 57 Orphan Designation 57 gets USFDA nod 57 Pennsaid Plus 57 Loramyc ™ 57 Receives Fast Track 57 XIAPEX 57 REGPARA 57 Fortical R 57 laninamivir 57 5mg #mg #mg 57 corporate website www.takeda.com 57 Submits Supplemental 57 Application BLA 57 CryoSeal 57 Launches Generic Version 57 CELVAPAN H#N# 57 OMNARIS 57 Plenaxis TM 57 Handok 57 Files IND 57 Cefdinir 57 Somatuline Depot 57 Receives Tentative FDA 57 Multiferon R 57 Initiate Clinical Trial 57 Fludara ® 57 Nintendo Wii outsells PS3 57 Tamsulosin 57 levocetirizine 57 IV acetaminophen 57 Receives Positive Opinion 57 Entocort 57 Santen Pharmaceutical Co. 57 lubiprostone 57 Velaglucerase Alfa 57 Nycomed GmbH 57 ZEGERID Chewable Tablets 57 BioSante Pharmaceuticals Announces 57 SUMAVEL 57 hoFH 57 Sanvar R 56 POSIDUR TM 56 ThermoDox ® 56 pitavastatin 56 ORTHOVISC mini 56 PROMACTA 56 DAYTRANA TM 56 Frova ® 56 fipamezole 56 DepoDur 56 Nexavar ® 56 Orphan Drug status 56 CIP Fenofibrate 56 Generic Version 56 Pennsaid R 56 Viviant 56 Daiichi Suntory Pharma 56 Oncolys 56 ORENCIA ® 56 Marketing Authorization 56 Kyowa Hakko Kogyo 56 ® decitabine 56 Teva Provides Update 56 vinorelbine tartrate 56 Roche Chugai 56 solifenacin succinate 56 Rheumatoid Arthritis Drug 56 OMAPRO ™ 56 vancomycin hydrochloride 56 Panzem R 56 nasal calcitonin product 56 MAGE A3 ASCI 56 Pegloticase 56 Receives Orphan Drug 56 Nippon Soda 56 Ixempra 56 Proquin XR 56 Gleevec Glivec 56 Alogliptin 56 AnGes MG 56 NerPharMa 56 Renvela ® 56 Cholestagel ® 56 Metformin Hydrochloride 56 Kepivance 56 Pirfenidone 56 Misonix Announces 56 Kyorin Pharmaceutical 56 DIFICID ™ 56 companies visit www.tpna.com 56 Ono Pharmaceutical 56 Simulect 56 please visit www.eisai.com 56 orphan designation 56 Grants Orphan Drug 56 Generic Version Of 56 Glargine 56 BLA filing 56 PDUFA Date 56 Japanese Encephalitis vaccine 56 Otsuka Pharmaceuticals 56 enoxaparin sodium injection 56 Accelerated Assessment 56 Methylphenidate Transdermal System 56 vapreotide acetate 56 BioDelivery Sciences Announces 56 proprietary intravenous formulation 56 Efient 56 Glucomed 56 Dainippon Sumitomo 56 ruxolitinib 56 TRISENOX 56 Firazyr 56 ciprofloxacin hydrochloride 56 Allegra Oral Suspension 56 Aplenzin 56 Oxcarbazepine 56 BEMA Fentanyl 56 AzaSite Xtra 56 BARACLUDE R 56 Morphine Sulfate 56 Fortovase 56 oral salmon calcitonin 56 SEASONALE R 56 mometasone furoate 56 pioglitazone HCl 56 SUTENT ® 56 GTC recombinant form 56 ABILIFY R 56 ZEFTERA ™ 56 sublingual tablets 56 Psoriasis Drug 56 Lamictal ODT 56 InvaGen 56 Mimpara 56 Positive Opinion 55 Sanvar 55 Toctino ® 55 Fortigel 55 Æterna Zentaris 55 Enhanze Technology 55 Keppra ® XR 55 Zirgan 55 injectable formulations 55 HFA MDI 55 PEG INTRON 55 Neulasta R 55 VALSTAR 55 Basilea Toctino R 55 Sebivo 55 pantoprazole sodium 55 Cinacalcet HCl 55 Ramelteon 55 markets HP Acthar 55 Orphan Drug Status 55 subcutaneous formulation 55 Submits Investigational 55 GLASSIA 55 ANDA submission 55 commercialize ZYFLO CR 55 Nichi iko 55 Kissei 55 MethyPatch 55 supplemental biologics 55 Centralized Procedure 55 ATryn ® 55 Cefixime 55 Increlex R 55 Zenpep 55 G#DT 55 SOLODYN R 55 Eloxatin ® 55 Kyowa Kirin 55 Nebido 55 metoprolol succinate 55 Kyowa Hakko Kogyo Co. 55 FDA Approvable Letter 55 NEBIDO 55 IMiDs ® compound 55 commercialize peramivir 55 MEZAVANT 55 Oxaliplatin 55 valtorcitabine 55 GATTEX TM 55 Aloprim TM allopurinol sodium 55 Satraplatin 55 VIVITROL ® 55 Orally Disintegrating Tablets 55 Takeda Pharma 55 Olmesartan 55 LIVALO 55 ixabepilone 55 DPP4 inhibitor 55 DepoBupivacaine TM 55 FOLOTYN ® 55 Pfizer Norvasc 55 intravenous acetaminophen 55 fluvoxamine maleate 55 Advagraf 55 authority Gurian Sherman 55 Bafna Pharma 55 Alvesco ® 55 Asahi Kasei Pharma 55 Voraxaze 55 Targretin capsules 55 iv peramivir 55 Sumatriptan Succinate Tablets 55 Vertex hepatitis C 55 indiplon capsules 55 Orphan designation 55 Teikoku Seiyaku Co. 55 Tesamorelin 55 Kuhnil 55 generation purine nucleoside 55 Mepact 55 Astellas Pharma #.T 55 rabeprazole sodium 55 Oracea TM 55 Rescula 55 orally disintegrating 55 PLAVIX R clopidogrel bisulfate 55 MAA submission 55 highly purified pasteurized 55 THELIN 55 Shionogi 55 LO LOESTRIN FE 55 etanercept Enbrel 55 fexofenadine hydrochloride 55 designated Restanza 55 Generic Versions 55 Entecavir 55 STRIANT ® 55 Arzerra TM 55 SEBIVO 55 SEASONALE 55 DepoDur TM 55 pancreatic enzyme replacement 55 Certican 55 granted Ortec 55 Zelnorm Zelmac 55 Shin Poong 55 Biological License Application 55 Angiox 55 Zingo TM 55 Nascobal 55 R imatinib mesylate 55 supplemental Biologics License Application 55 Completes Patient Enrollment 55 Divalproex Sodium 55 BiDil XR 55 Reclast Aclasta 55 ULTRASE 55 ELIQUIS 55 Genzyme Myozyme 55 Junovan TM 55 prasterone 55 SPRIX ® 55 Aphthasol R 55 commercialize telaprevir 55 Campto 55 PROTONIX 54 intravenous AAT 54 Resubmission 54 ASP# 54 Ecallantide 54 Cytokinetics specified 54 TELINTRA 54 Polyphenon ® E 54 Iluvien ® 54 Tamibarotene 54 TRISENOX ® 54 Brinavess 54 mesylate 54 #mg dosage strength 54 Impavido R 54 Oncoscience AG 54 Lambert Eaton Myasthenic 54 cyclobenzaprine hydrochloride extended 54 Reloxin R 54 Obtains FDA 54 Milestone Payments 54 Solzira TM 54 Allovectin 7 ® 54 Premarket Approval 54 assigned PDUFA 54 Auxilium Pharma 54 oxaliplatin Eloxatin 54 UCB Keppra 54 Silenor ® doxepin 54 Vantas 54 acyclovir Lauriad R 54 Tekamlo 54 Metformin GR 54 k Premarket Notification 54 Fast Track Designation 54 Silodosin 54 Egrifta 54 Onyx Pharma 54 palonosetron 54 Medicinal Products EMEA 54 Act PDUFA date 54 Investigational Compound 54 Terbinafine 54 Teflaro 54 Toctino R 54 VYVANSE TM lisdexamfetamine 54 ZEGERID Capsules 54 galantamine hydrobromide 54 Nihon Kohden Corporation 54 Panzem R NCD 54 FUSILEV ® 54 HIV integrase inhibitor 54 Zemiva TM 54 STRIANT R 54 Besivance 54 Antitumor 54 Galantamine 54 ADDERALL XR R 54 Expedited Review 54 SILENOR 54 pulls Darvon painkiller 54 CIP ISOTRETINOIN 54 Allovectin 7 r 54 Emend 54 HepaGam B 54 Qutenza TM 54 Sanctura XR 54 Emezine R 54 Product Monograph 54 PROMACTA ® 54 Nascobal Nasal Spray 54 Hematide ™ peginesatide 54 Removab 54 Bendamustine 54 Patients Treated With 54 oropharyngeal candidiasis 54 Troxatyl TM 54 Seikagaku 54 FACTIVE R gemifloxacin 54 Pariet 54 XL# anticancer compounds 54 Xcytrin R 54 Sosei 54 Yakult Honsha 54 corticotropin injection 54 TWYNSTA ® 54 Taiho Pharmaceutical Co. 54 Alitretinoin 54 Xifaxan rifaximin 54 mesylate tablets approved 54 Nexavar sorafenib tablets 54 Pivotal Phase III 54 Abstral ® 54 Kuvan sapropterin dihydrochloride 54 Valtropin 54 AzaSite Plus 54 Arzerra ofatumumab 54 Telavancin 54 BEMA Granisetron 54 Vidaza azacitidine 54 Novartis NVS Snapshot Report 54 Marketing Authorizations 54 amifampridine phosphate 54 Mitsubishi Pharma 54 BYDUREON ™ 54 anagrelide hydrochloride 54 BugOil R 54 Submits Application 54 PNP inhibitor 54 IONSYS TM 54 diquafosol tetrasodium 54 Drug Administration KFDA 54 IMPDH inhibitor 54 Kyowa Hakko Kirin 54 QAB# indacaterol 54 buccal spray 54 Begin Clinical Trials 54 Tolvaptan 54 Contrave NDA 54 Gralise 54 Aceon 54 Liprotamase 54 miconazole Lauriad 54 please visit www.innercool.com 54 sumatriptan succinate 54 ELAPRASE 54 NDA Submission 54 Benazepril 54 ONGLYZA ™ 54 Anturol TM 54 EGRIFTA TM 54 Erwinase 54 TAXUS Element Stent System 54 Granulocyte Colony Stimulating Factor 54 ANDA Filing 54 Combunox 54 FIRAZYR 54 Orphan Status 54 Bazedoxifene 54 Oncolys BioPharma 54 hydrochloride tablets 54 CIMZIA r 54 Astellas 54 Eligard ® 54 Telzir 54 Fenoglide 54 Sumavel DosePro 54 lucinactant 54 SNT MC# 54 Ambrisentan 54 VIVUS Announces 54 IPM Wound Gel 54 Esbriet pirfenidone 54 vernakalant IV 54 Tanabe Seiyaku 54 ZALBIN 54 Biophan patent 54 RHEI 54 Quinapril 54 Tanabe Seiyaku Co. 54 Marketing Authorization Application MAA 54 designated cethromycin 54 OTC Zegerid 54 Tekturna Rasilez 54 Asmanex 54 XP# XP# 54 Joulferon 54 Atelvia 54 Kyowa Hakko 54 EDQM 54 Eraxis 54 Suprax 54 Gets FDA Clearance 54 LymphoStat B belimumab 54 KYNAPID 54 R bendamustine hydrochloride 54 Kristalose ® lactulose 54 HCl capsules 54 Supplemental Biologics License Application 54 Vimpat ® lacosamide 54 Somatuline R Depot 54 Lamivudine 54 received CE Conformite 54 Initiates Phase III 54 Thelin TM 54 LymphoStat B TM 54 OLEPTRO 54 Expanded Indication 54 Biologics Licensing 54 Hiberix 54 Sensipar 54 registrational studies 54 Kaketsuken 54 Glucophage XR 54 rThrombin 54 Receives CE Marking 54 commercialize AzaSite 54 eprodisate Fibrillex TM 53 Metricath Gemini 53 LHRH antagonist 53 Dainippon Pharmaceutical 53 KDDIF 53 OMP designation 53 reslizumab 53 commercialize toremifene 53 Premarket Approval Application 53 please visit www.dsi.com 53 Xyrem ® 53 faropenem 53 Friedreich Ataxia FRDA 53 Celgene Thalomid 53 Uracyst ® 53 novel VDA molecule 53 Demonstrates Potential 53 amrubicin 53 Aryplase 53 tivozanib AV 53 Orathecin 53 Icatibant 53 Mutual Recognition Procedure 53 Mitsubishi Tanabe Pharma 53 Toyama Chemical 53 HepeX B 53 ARIXTRA R 53 Kissei Pharmaceuticals 53 Successfully Completes Phase 53 Fanapt ™ 53 Ereska 53 NUEDEXTA ™ 53 Cintredekin besudotox 53 Taisho Pharmaceutical 53 Vesicare 53 Reloxin ® 53 Hectorol R 53 Testosterone Gel 53 Bonefos 53 Berinert 53 biosimilar filgrastim 53 successfully commercialize Silenor 53 RELISTOR ® 53 Copegus R 53 sirtuin modulators 53 Neuromodulation System 53 Daiichi Pharmaceutical 53 Aloxi ® 53 PDUFA Prescription Drug 53 Eucreas 53 Otsuka Pharmaceutical 53 Onalta 53 Initiate Phase II 53 fesoterodine 53 Cefprozil tablets 53 DP VPA 53 Requip XL 53 ONSOLIS 53 Mochida Pharmaceutical Co. 53 IND Application 53 Actemra tocilizumab 53 GRAS notification 53 Flutiform ™ 53 Brilique 53 Kyorin 53 Dantrium R 53 Phenoptin 53 Boniva ibandronate 53 Archexin 53 Banyu Pharmaceutical Co. 53 KRYSTEXXA TM pegloticase 53 SinuNase TM 53 naproxen esomeprazole magnesium 53 Priligy 53 intranasal formulation 53 Sankyo Co. 53 Humira adalimumab 53 Initiates Clinical Trial 53 Takeda Pharmaceutical Company 53 Adjuvant Treatment 53 Uplyso 53 silodosin 53 Loxapine 53 Marqibo TM 53 Femring ® 53 Anidulafungin 53 Dainippon Sumitomo Pharma 53 PDE4 inhibitor 53 tolperisone 53 Zorbtive TM 53 ATL# [002] 53 risedronate sodium tablets 53 Apaziquone 53 telavancin NDA 53 Salix Pharma 53 Firdapse 53 Sertraline Hydrochloride Tablets 53 Campath ® 53 Rasilez HCT 53 Stavzor 53 Personalized Immunotherapy 53 OLEPTRO ™ 53 Zolpimist 53 Cetrotide R 53 Dermylex R 53 Evoltra 53 PROVIGIL 53 severe hypercholesterolemia 53 DOXIL R 53 thalidomide Thalomid 53 transgenically produced product 53 RAPTIVA 53 FACTIVE tablets 53 Kuvan R 53 paliperidone palmitate 53 AstraZeneca Toprol XL 53 sevelamer carbonate 53 PROVENGE ® 53 LGLS 53 Adenuric ® 53 Falk Pharma 53 UMN Pharma 53 EGRIFTA ™ 53 IV APAP 53 Orphan Medicinal Product 53 Eszopiclone 53 DigiFab TM 53 Zenapax 53 NB S# strontium malonate 53 Adenuric 53 PentaLyte R 53 TRANSDUR Sufentanil 53 JCR Pharmaceuticals 53 bazedoxifene 53 ezogabine 53 Idenix Novartis 53 HepaGam B R 53 Pliaglis 53 Taiho 53 Xenazine ® 53 TheraCIM 53 Injectable Solution 53 Patent Covering 53 Biologic License Application 53 miconazole Lauriad R 53 Remodulin 53 Kamada AAT 53 Virulizin R 53 #D#C# 53 Entereg TM 53 XYZAL 53 Orphan Drugs 53 FDA Okays 53 orphan medicinal product 53 Urocidin 53 Simvastatin tablets 53 Ferumoxytol 53 Tumor Response 53 Release Capsules 53 ATPace TM 53 diarrhea predominant irritable 53 BioSante licensees 53 LEVADEX ™ 53 Japanese drugmaker Daiichi 53 topical gel formulation 53 rasagiline tablets 53 ATryn R 53 ABILIFY ® 53 Mirapexin 53 Potelligent Technology 53 Rebetol 53 ZARS Pharma 53 Oral Solution 53 PLAVIX ® 53 Surgical Adhesive 53 Vidaza R 53 Cancidas 53 inhaled AAT 53 Nihon Pharmaceutical 53 GENERIC SILDENAFIL SOFT Generic 53 Release Tablets 53 granisetron hydrochloride 53 Astellas Pharmaceuticals 53 Evoltra R 53 Megace R ES 53 vinflunine 53 Approvable 53 GLASSIA ™ 53 Meets Primary Endpoint 53 Votrient 53 ONTAK 53 Fibrillex TM 53 Grünenthal GmbH 53 Investigational Treatment 53 BioNumerik 53 Immunosuppressant 53 RYZOLT 53 Kaneka Corporation 52 daily Glumetza TM 52 Gentamicin Surgical Implant 52 THALOMID 52 ZEVALIN ® 52 ZETIA 52 NSE SUNPHARMA 52 Allovectin 7 R 52 aerosolized AAT 52 Taisho Pharmaceutical Co. 52 liposomal formulation 52 PROCHIEVE ® 52 Dynepo 52 Combidex 52 LibiGel ® 52 Regeneron Pharma 52 Xerclear TM 52 Wellstat 52 Movectro 52 Suzuken 52 Approvable letter 52 Taisho Pharmaceutical Co 52 Avanafil 52 Synerx Pharma 52 Mitsubishi Tanabe 52 Veregen R 52 Kuvan TM sapropterin 52 application sNDA 52 alvimopan 52 Vitaros 52 LUCASSIN 52 methylnaltrexone 52 risedronate sodium 52 HuMax TAC 52 Phase 2a Trial 52 MK #B 52 ATryn ® GTC recombinant 52 ENZON 52 PHX# 52 Stedesa 52 Marketing Authorization Application 52 Mycophenolate Mofetil 52 Cleviprex TM clevidipine 52 IV Busulfex 52 oral methylnaltrexone 52 known teratogen substance 52 Sets Tentative 52 Glumetza 52 XIBROM 52 Teveten 52 Metvix 52 Actoplus Met 52 5 HT2A inverse 52 Onco TCS 52 Surfaxin lucinactant 52 Amplimexon 52 Erythropoiesis Stimulating Agents ESAs 52 Bayer Onyx 52 VIMOVO 52 Namenda XR 52 Actonel ® 52 Angiox ® 52 Vectical 52 Sanofi Aventis Taxotere 52 Cladribine 52 Dapagliflozin 52 Xolegel 52 Arranon 52 ENTEREG ® 52 OPANA ER 52 Velcade bortezomib 52 Prilosec omeprazole 52 Extended Release 52 Abstral 52 dalbavancin 52 Prestara TM 52 ARCOXIA 52 Aflibercept 52 outlicensed 52 MONOVISC 52 LIALDA 52 Biologics License Applications 52 Yakult Honsha Co. 52 TaiGen Biotechnology 52 BENLYSTA ® 52 Par Pharma 52 Ube Industries 52 DDP# 52 Orazol 52 Roche Actemra 52 XIAFLEX ™ 52 AmBisome 52 TRANSDUR ® 52 Avoid jalapenos 52 Livalo 52 Chugai Pharma 52 sumatriptan injection 52 Sancuso 52 Torii Pharmaceutical 52 Daytrana ® 52 DAIICHI SANKYO COMPANY LIMITED 52 prescription laxative 52 Tofacitinib 52 Nippon Chemiphar 52 Fingolimod 52 STERIS Corporation Announces 52 voclosporin 52 Astellas Pharma 52 Initiate Phase 52 Allos retains exclusive 52 Chugai Pharmaceutical Co 52 TRANSDUR Bupivacaine 52 ceftazidime 52 vernakalant hydrochloride 52 Velac 52 Remicade infliximab 52 thetreatment 52 ATD gel 52 commercialize omecamtiv mecarbil 52 filgrastim 52 prokinetic agent 52 AZOR TM 52 RANK Ligand inhibitor 52 Blopress 52 XENAZINE 52 Vasovist 52 tafluprost 52 rhLF 52 commercialize CorMedix drug 52 UCB Cimzia 52 Pegintron 52 ACEON R perindopril erbumine 52 Generic Lovenox 52 selective receptor agonist 52 XIENCE V Stent System 52 RoACTEMRA 52 Orphan Drug 52 Phase III Clinical Trial 52 TYGACIL 52 LEP ETU 52 Orally administered 52 Recommends Approval 52 Takara Bio 52 Receives Approval From 52 ABLAVAR ® 52 SymBio 52 Chugai Pharmaceutical Co. 52 Techpool 52 NV Organon 52 Doryx 52 Exalgo TM 52 pralatrexate injection folate analogue 52 Fresenius Kabi Oncology 52 EpiCeram 52 cMET inhibitor 52 ACUROX 52 satraplatin